Cholangitis, Sclerosing

• 

  Subject Areas on Research

  • Association of primary sclerosing cholangitis and celiac disease: a case report and review of the literature. 
  • Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. 
  • Chronic abdominal pain in a liver transplant recipient. 
  • Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis. 
  • Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. 
  • De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant. 
  • Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO. 
  • Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy. 
  • Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis. 
  • Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial. 
  • Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease. 
  • Is Magnetic Resonance Cholangiopancreatography Worth a Thousand Words in Determining Prognoses of Patients With Primary Sclerosing Cholangitis? 
  • Liver transplantation in a patient with primary sclerosing cholangitis suffering from lipomatous pseudohypertrophy of the pancreas. 
  • MR cholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the single-shot fast spin-echo technique. 
  • Management of primary sclerosing cholangitis. 
  • Noninvasive markers in the assessment and management of autoimmune liver diseases. 
  • Outcomes of liver retransplantation in patients with primary sclerosing cholangitis. 
  • Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography. 
  • Purine nucleoside phosphorylase deficiency with fatal course in two sisters. 
  • Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. 
  • Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. 
  • Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury. 
  • Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease. 
  • Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis. 
  • Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. 
  • The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis. 
  • The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. 
  • The role of cystic fibrosis gene mutations in determining susceptibility to chronic pancreatitis. 
• 

  Keywords of People

  • Muir, Andrew Joseph, Professor of Medicine, Medicine, Gastroenterology